TNFSF4 and neoplasm: Taken together, the PD1-Fc-OX40L ARC is able to simultaneously block immunosuppressive checkpoint signaling while also providing a costimulatory signal to T cells; thereby facilitating a potent cytotoxic anti-tumor response.